Perspective is leading human capital innovation in healthcare.  In this period of disruption, healthcare and HR leaders are being pressed to redefine how they organize, recruit, develop, manage and engage their workforce. At Perspective, we leverage our ability to understand the strategic and operational priorities of our healthcare clients together with our insight into an evolving human capital landscape. As opposed to one-off projects, we identify ways to integrate more formally into our clients’ business with a unique set of services. We devise actionable human capital solutions resulting in measurable and sustained business impact. It is this integrated human capital™ approach that we leverage for the benefit of our clients.

With regard to our Board and Executive Search work, we are pleased to introduce our initial quarterly announcement. Looking back on 2017, it has proved to be an exciting year for both healthcare and human capital. Please see below, a list of several of our 2017 placements.

PLACEMENTS

Board Members

Mary Lynne Hedley, PhD, COO at TESARO | Director at bluebird bio

John Agwunobi, MD, former SVP, President, Health & Wellness at Walmart | Director at bluebird bio

Douglas Melton, PhD, Xander University Professor at Harvard University | Director at bluebird bio

Michael Minogue, Chairman, President & CEO at Abiomed | Director at Insulet

James Mullen, CEO of Patheon NV | Director at Insulet

Kevin Conroy, Chairman, President & CEO at Exact Sciences | Director at Epizyme

Eli Casdin, Managing Member, Casdin Capital | Director at Exact Sciences

Jacqualyn Fouse, PhD, President & COO at Celgene | Director at Incyte

Geno Germano, former Global Head, Innovative Pharma Business at Pfizer | Director at Bioverativ

 

Chief Executive Officer | Chief Operating Officer

Vince Angotti, CEO at AcelRx Pharmaceuticals

Jeffrey Hatfield, CEO at Zafgen

William McVicar, PhD, CEO at Flex Pharma

Joseph Ciaffoni, EVP and COO at Collegium Pharmaceutical

Christine Carberry, COO at Keryx Biopharmaceuticals

 

Finance

Tom Graney, CFO at Vertex Pharmaceuticals

Senthil Sundaram, CFO at Nightstar Therapeutics

Kory Wentworth, Vice President, Finance and Principal Accounting Officer at bluebird bio

 

Commercial

Jason Meyenburg, CCO at Vtesse

Andrew Robertson, VP & GM, Head of Europe at Sarepta Therapeutics

 

Business Development

Hugh Cole, CBO at Jounce Therapeutics

Aaron Schuchart, CBO at Aeglea BioTherapeutics

Jeremy Springhorn, PhD, CBO at Syros Pharmaceuticals

Devyn Smith, PhD, CSO, Head of Operations at Sigilon Therapeutics

Tanja Weber, VP, Business Development at Agios Pharmaceuticals

Ilan Zipkin, PhD, VP, Business Development at The Parker Institute for Cancer Immunotherapy

Paul Stead, PhD, VP, Business Development at Adaptimmune Therapeutics

 

Healthcare IT

John Marron, General Manager, Revenue Cycle Management at AdvancedMD

 

Research & Development

Lon Cardon, PhD, CSO at BioMarin Pharmaceutical

Tuyen Ong, MD, CDO at Nightstar Therapeutics

 

Technical Operations

Clive Patience, PhD, SVP, Technical Operations at Agios Pharmaceuticals